Xin Du

7PUBLICATIONS
46CO-AUTHORS
Haematological tumoursTraditional Chinese medicine and treatmentsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2025
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study.

Yiling Ye, Xinyu Liu, Huajuan Dai

|Nov 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.

Guopan Yu, Yu Zhang, Sijian Yu

|Jun 20, 2024
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.

Jian Cui, Xiaoyun Li, Shuhui Deng

|Mar 11, 2024
Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells.

Miao Li, Chang-Lin Zhang, Di-Sheng Zhou

|Sep 25, 2023
Downregulation of RCN1 promotes pyroptosis in acute myeloid leukemia cells.

Sisi Deng, Yuming Pan, Na An

|Apr 06, 2023
Anti-Acute Myeloid Leukemia Activity of CD38-CAR-T Cells with PI3Kδ Downregulation.

Na An, Yuming Pan, Linlin Yang

Pageof 2

Frequent Collaborators

2 joint publications

Li Xuan

2 joint publications

Hua Jin

2 joint publications

Min Dai

2 joint publications

Qifa Liu